Sunshine Biopharma, Inc. – NASDAQ:SBFMW

Sunshine Biopharma stock price today

$0.14
-0.08
-39.09%
Financial Health
0
1
2
3
4
5
6
7
8
9

Sunshine Biopharma stock price monthly change

+91.67%
month

Sunshine Biopharma stock price quarterly change

+91.67%
quarter

Sunshine Biopharma stock price yearly change

+15.00%
year

Sunshine Biopharma key metrics

Market Cap
 7.15M
Enterprise value
 N/A
P/E
 -0.2
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 17.31
Price/Book
 0.21
PEG ratio
 116.14
EPS
 -13.33
Revenue
 26.73M
EBITDA
 -3.44M
Income
 -4.08M
Revenue Q/Q
 54.08%
Revenue Y/Y
 193.29%
Profit margin
 -522.53%
Oper. margin
 -797.91%
Gross margin
 46.71%
EBIT margin
 -797.91%
EBITDA margin
 -12.9%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Sunshine Biopharma stock price history

Sunshine Biopharma stock forecast

Sunshine Biopharma financial statements

Profit Margin

Sunshine Biopharma, Inc. (NASDAQ:SBFMW): Profit margin
Jun 2023 5.56M -902.10K -16.22%
Sep 2023 5.95M -651.48K -10.94%
Dec 2023 7.68M -1.25M -16.28%
Mar 2024 7.54M -1.28M -17.02%
SBFMW income statement history

Debt to Assets

Sunshine Biopharma, Inc. (NASDAQ:SBFMW): Debt to assets
Jun 2023 28410022 5.30M 18.66%
Sep 2023 27650284 5.68M 20.57%
Dec 2023 27346961 6.13M 22.45%
Mar 2024 31898717 7.07M 22.19%
SBFMW balance sheet history

Cash Flow

Sunshine Biopharma, Inc. (NASDAQ:SBFMW): Cash Flow
Jun 2023 -3.77M -259.47K 4.05M
Sep 2023 -457.28K 18.85K -63.56K
Dec 2023 -2.68M -269.23K -30.51K
Mar 2024 -3.18M -668.73K 5.39M
SBFMW cash flow history

Sunshine Biopharma alternative data

Sunshine Biopharma
Employees

Sunshine Biopharma, Inc. (NASDAQ:SBFMW): Employee count
Aug 2023 46
Sep 2023 46
Oct 2023 46
Nov 2023 46
Dec 2023 46
Jan 2024 46
Feb 2024 46
Mar 2024 46
Apr 2024 46
May 2024 44
Jun 2024 44
Jul 2024 44

Sunshine Biopharma other data

Sunshine Biopharma
Hedge Funds Holdings Q1 2023

0.01% -0.20%
of SBFMW is owned by hedge funds
2 -1
hedge funds hold SBFMW stock
2.07K -37.63K
shares is hold by hedge funds
SBFMW hedge funds holdings changes

Sunshine Biopharma
Insider Trading

Sunshine Biopharma, Inc. (NASDAQ:SBFMW): Insider trades (number of shares)
Period Buy Sel
Jun 2022 25000 0
Nov 2022 30000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
SEBAALY CAMILLE officer: CFO/Secr.. Common Stock 30,000 $0.76 $22,920
Purchase
SEBAALY CAMILLE officer: CFO/Secr.. Common Stock 25,000 $1.22 $30,500
SBFMW insider trading transactions

Frequently Asked Questions (FAQ)

  • What's the price of Sunshine Biopharma stock today?

    One share of Sunshine Biopharma stock can currently be purchased for approximately $0.14.

  • When is Sunshine Biopharma's next earnings date?

    Unfortunately, Sunshine Biopharma's (SBFMW) next earnings date is currently unknown.

  • Does Sunshine Biopharma pay dividends?

    No, Sunshine Biopharma does not pay dividends.

  • How much money does Sunshine Biopharma make?

    Sunshine Biopharma has a market capitalization of 7.15M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 454.42% to 24.09M US dollars.

  • What is Sunshine Biopharma's stock symbol?

    Sunshine Biopharma, Inc. is traded on the NASDAQ under the ticker symbol "SBFMW".

  • What is Sunshine Biopharma's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of Sunshine Biopharma?

    Shares of Sunshine Biopharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Sunshine Biopharma have?

    As Jul 2024, Sunshine Biopharma employs 44 workers, which is 4% less then previous quarter.

  • When Sunshine Biopharma went public?

    Sunshine Biopharma, Inc. is publicly traded company for more then 3 years since IPO on 15 Feb 2022.

  • What is Sunshine Biopharma's official website?

    The official website for Sunshine Biopharma is sunshinebiopharma.com.

  • Where are Sunshine Biopharma's headquarters?

    Sunshine Biopharma is headquartered at 6500 Trans-Canada Highway, Pointe-Claire, QC.

  • How can i contact Sunshine Biopharma?

    Sunshine Biopharma's mailing address is 6500 Trans-Canada Highway, Pointe-Claire, QC and company can be reached via phone at +33 22161147.

Sunshine Biopharma company profile:

Sunshine Biopharma, Inc.

sunshinebiopharma.com
Exchange:

NASDAQ

Full time employees:

44

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound. It also offers Essential 9, a nutritional supplement tablet; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name, as well as develops and markets other science-based nutritional supplements. The company has a license agreement with the University of Georgia to advance the development of its anti-coronavirus lead compound, SBFM-PL4. Sunshine Biopharma, Inc. is headquartered in Pointe-Claire, Canada.

+33 22161147
6500 Trans-Canada Highway
Pointe-Claire, QC H9R 0A5

CIK: 0001402328
ISIN: US8677815024
CUSIP: 867781502